CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 17 -1.50 (-8.11%) As of 05/23/2025 04:46 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 70.00%. In the past month, the stock has increased 109.10%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 17 with a market cap of £1.85 million and volume of 1,050 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+109.10%3 Month Performance+152.98%Year-To-Date Performance+70.00% CRTX Stock Chart for Sunday, May, 25, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025GBX 20GBX 17-15.00%GBX 18.50GBX 171,050 shs£1.85 million05/22/2025GBX 17GBX 20+17.65%GBX 20GBX 17.36720 shs£2.18 million05/21/2025GBX 17GBX 17GBX 18.50GBX 1710,922 shs£1.85 million05/20/2025GBX 19GBX 17-10.53%GBX 20GBX 1792,987 shs£1.85 million05/19/2025GBX 18GBX 19+5.56%GBX 19GBX 1799,080 shs£2.07 million05/16/2025GBX 20.90GBX 18-13.88%GBX 19.90GBX 1875,724 shs£1.96 million05/15/2025GBX 21.20GBX 20.90-1.42%GBX 24GBX 1926,570 shs£2.28 million05/14/2025GBX 21.10GBX 21.20+0.47%GBX 24.55GBX 21130,799 shs£2.31 million05/13/2025GBX 21GBX 21.10+0.48%GBX 26GBX 17.77369,090 shs£2.30 million05/12/2025GBX 18.50GBX 21+13.51%GBX 21GBX 16.33186,028 shs£2.29 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025GBX 20GBX 18.50-7.50%GBX 22GBX 16.70146,224 shs£2.02 million05/08/2025GBX 17.16GBX 20+16.55%GBX 22GBX 1882,498 shs£2.18 million05/07/2025GBX 15.88GBX 17.16+8.06%GBX 20GBX 13.65205,055 shs£1.87 million05/06/2025GBX 21.76GBX 15.88-27.02%GBX 22GBX 13.26241,499 shs£1.73 million05/05/2025GBX 21.76GBX 21.76GBX 29.40GBX 15.16887,944 shs£2.37 million05/02/2025GBX 16.01GBX 21.76+35.92%GBX 29.40GBX 15.16887,944 shs£2.37 million05/01/2025GBX 13.55GBX 16.01+18.15%GBX 17GBX 1291,046 shs£1.74 million04/30/2025GBX 14.30GBX 13.55-5.24%GBX 15GBX 11.20269,713 shs£1.48 million04/29/2025GBX 10.62GBX 14.30+34.65%GBX 14.80GBX 10.50285,312 shs£1.56 million04/28/2025GBX 8.13GBX 10.62+30.63%GBX 13.80GBX 8.33132,589 shs£1.16 million04/25/2025GBX 9.90GBX 8.13-17.88%GBX 10.85GBX 8113,343 shs£886,000.0004/24/2025GBX 8.25GBX 9.90+20.00%GBX 9.90GBX 810,250 shs£1.08 million Related Companies Tirupati Graphite Stock Price Chart Phoenix Copper Stock Price Chart Celsius Resources Stock Price Chart Vast Resources Stock Price Chart Strategic Minerals Stock Price Chart Firering Strategic Minerals Stock Price Chart PYX Resources Stock Price Chart GreenRoc Mining Stock Price Chart CleanTech Lithium Stock Price Chart Cadence Minerals Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRTX Stock Free CRTX Stock Alerts